AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Epimmune, Bavarian Nordic Combine Technologies To Develop HIV Vaccine.(Brief Article)
2001 DEC 26 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) and Bavarian Nordic A/S (BAVA) have entered into a collaboration agreement to combine their technologies to develop vaccines for the treatment or prevention of HIV infection.
Under the agreement, the companies will combine Epimmune's technology and expertise in the fields of T-cell epitope (protein fragment) identification and vaccine design with Bavarian Nordic's vaccine delivery technology, modified vaccinia ankara (MVA), and its development and manufacturing expertise to design and develop both therapeutic and prophylactic HIV vaccines. The nonexclusive agreement allows the companies to work together with the combined technology in the HIV field. In addition, Bavarian Nordic retains the worldwide, exclusive rights to manufacture vaccines resulting from the collaboration, subject to the terms of the agreement. Financial terms of the agreement were not disclosed.
"Combining our expertise in creating epitope-based vaccines that direct the immune system to the conserved regions of multiple HIV proteins with Bavarian Nordic's proven MVA vaccine delivery expertise and ...
- Epimmune and Bavarian Nordic Combine Technologies to Develop HIV Vaccine.
- Press release article from: PR Newswire November 29, 2001 700+ words
...COPENHAGEN, Denmark -- Epimmune Inc. and Bavarian Nordic A/S (Copenhagen...http://www.epimmune.com/. About Bavarian Nordic Bavarian Nordic is...being developed by Epimmune and Bavarian Nordic under this collaboration...
- Epimmune Awarded $16.7 Million National Institutes of Health Contract For HIV...
- Press release article from: PR Newswire September 29, 2003 700+ words
...testing in humans. Epimmune will lead a consortium that will include Bavarian Nordic A/S in Denmark and...both in the U.S. Epimmune will use its proprietary...immune response. Epimmune and Bavarian Nordic will jointly test...
- HIV Vaccine Grant Boosts Epimmune; San Diego Biotech Firm to Lead Consortium.
- Newspaper article from: Knight Ridder/Tribune Business News September 30, 2003 700+ words
...Botswana, Africa. The grant calls for Epimmune to lead a consortium that will include Bavarian Nordic of Denmark and Althea Technologies in the United States. Epimmune and Bavarian Nordic will jointly test an epitope vaccine...
- Bavarian Nordic A/S Enforces its Intellectual Property Rights Against Acambis...
- Press release article from: PR Newswire Europe August 19, 2005 700+ words
...Tornau (IDT), Bavarian Nordic has ensured supply...and future vaccines. Bavarian Nordic's partners include GlaxoSmithKline, Epimmune in the U.S.A...please visit www.bavarian-nordic.com (i) The award...
- Bavarian Nordic and GlaxoSmithKline Enter Into Global Collaboration on IMVAMUNE.
- Press release article from: PR Newswire July 15, 2004 700+ words
...facility in Berlin, Germany, Bavarian Nordic has established its own...current and future vaccines. Bavarian Nordic's partners include Epimmune of the USA, Gerolymatos...information please visit www.bavarian-nordic.com "Safe Harbour...
- Bavarian Nordic A/S - Third Quarterly Report as of 30 September 2004.
- Press release article from: PR Newswire Europe October 26, 2004 700+ words
...this designation. Bavarian Nordic is one of the few companies...Tornau (IDT), Bavarian Nordic has ensured supply...and future vaccines. Bavarian Nordic's partners include GlaxoSmithKline, Epimmune in the U.S.A...
- Bavarian Nordic Awarded a USD 100 Million Contract From US Government to...
- Press release article from: PR Newswire Europe September 30, 2004 700+ words
...Tornau (IDT), Bavarian Nordic has ensured supply...and future vaccines. Bavarian Nordic's partners include...GlaxoSmithKline worldwide, Epimmune in the U.S.A...please visit www.bavarian-nordic.com "Safe Harbour...
- Bavarian Nordic Initiate a Phase II Clinical Trial with IMVAMUNE(TM) in HIV...
- Press release article from: PR Newswire Europe July 20, 2005 700+ words
...Tornau (IDT), Bavarian Nordic has ensured supply...and future vaccines. Bavarian Nordic's partners include GlaxoSmithKline, Epimmune in the U.S.A...please visit www.bavarian-nordic.com (1) The award...
Source: HighBeam Research, Epimmune, Bavarian Nordic Combine Technologies To Develop HIV...